Boston Scientific Corpora...

NYSE: BSX · Real-Time Price · USD
104.16
1.66 (1.62%)
At close: Aug 14, 2025, 3:59 PM
104.45
0.28%
Pre-market: Aug 15, 2025, 04:14 AM EDT

Boston Scientific Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18.49B 17.55B 16.75B 15.91B 15.23B 14.71B 14.24B 13.76B 13.4B 13.04B 12.68B 12.57B 12.33B 12.16B 11.89B 11.47B 11.2B 10.12B
Cost of Revenue
6.8B 6.7B 6.46B 5.98B 5.78B 5.57B 5.41B 5.28B 5.16B 5.1B 4.97B 4.87B 4.72B 4.6B 4.51B 4.53B 4.51B 4.39B
Gross Profit
11.69B 10.85B 10.29B 9.93B 9.45B 9.14B 8.83B 8.47B 8.24B 7.95B 7.71B 7.7B 7.6B 7.56B 7.38B 6.94B 6.68B 5.73B
Operating Income
3.1B 2.91B 2.65B 2.62B 2.51B 2.31B 2.18B 2.07B 1.98B 1.9B 1.84B 1.85B 1.83B 1.87B 1.77B 1.49B 1.31B 735M
Interest Income
22M 22M 22M 22M 22M 22M 22M 4M 5M 6M 10M 7M 7M 7M 4M 3M 3M 2M
Pretax Income
3B 2.48B 2.28B 2.2B 2.14B 2.15B 1.99B 1.88B 1.51B 1.43B 1.14B 866M 1.1B 908M 1.08B 1.21B 495M 165M
Net Income
2.5B 2.03B 1.85B 1.79B 1.83B 1.77B 1.59B 1.23B 912M 902M 699M 653M 884M 810M 1.04B 1.1B 524M 191M
Selling & General & Admin
6.49B 6.22B 5.98B 5.75B 5.43B 5.34B 5.19B 4.97B 4.85B 4.66B 4.51B 4.5B 4.44B 4.4B 4.36B 4.23B 4.15B 3.83B
Research & Development
1.84B 1.69B 1.62B 1.52B 1.47B 1.44B 1.42B 1.38B 1.36B 1.34B 1.32B 1.31B 1.28B 1.25B 1.2B 1.17B 1.18B 1.12B
Other Expenses
268M 38M 34M 36M 42M 45M 45M 46M 46M 45M 42M 40M 43M 44M 49M 52M 50M 46M
Operating Expenses
8.59B 7.95B 7.63B 7.31B 6.94B 6.83B 6.65B 6.4B 6.26B 6.05B 5.87B 5.85B 5.77B 5.69B 5.61B 5.46B 5.38B 4.99B
Interest Expense
399M 390M 375M 303M 287M 277M 272M 269M 267M 260M 488M 512M 533M 557M 351M 359M 364M 372M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
15.39B 14.65B 14.09B 13.29B 12.72B 12.4B 12.06B 11.68B 11.43B 11.14B 10.84B 10.72B 10.5B 10.29B 10.12B 9.98B 9.89B 9.39B
Income Tax Expense
502M 454M 436M 414M 319M 377M 393M 648M 600M 529M 443M 213M 220M 98M 37M 107M -29M -25M
Shares Outstanding (Basic)
1.48B 1.48B 1.47B 1.47B 1.47B 1.47B 1.47B 1.46B 1.45B 1.44B 1.43B 1.43B 1.43B 1.43B 1.43B 1.42B 1.42B 1.42B
Shares Outstanding (Diluted)
1.49B 1.49B 1.49B 1.49B 1.48B 1.48B 1.48B 1.48B 1.46B 1.45B 1.44B 1.44B 1.44B 1.44B 1.44B 1.44B 1.43B 1.43B
EPS (Basic)
1.70 1.38 1.26 1.22 1.25 1.21 1.08 0.82 0.60 0.59 0.45 0.42 0.58 0.53 0.69 0.73 0.33 0.10
EPS (Diluted)
1.68 1.36 1.25 1.21 1.24 1.20 1.07 0.82 0.59 0.59 0.45 0.42 0.58 0.53 0.69 0.73 0.33 0.10
EBITDA
4.38B 4.16B 3.92B 3.74B 3.66B 3.64B 3.45B 3.32B 2.94B 2.84B 2.77B 2.51B 2.76B 2.56B 2.52B 2.66B 1.96B 1.65B
EBIT
3.4B 2.87B 2.65B 2.5B 2.43B 2.42B 2.25B 2.15B 1.78B 1.69B 1.63B 1.38B 1.64B 1.47B 1.43B 1.56B 859M 538M
Depreciation & Amortization
980M 1.29B 1.27B 1.24B 1.23B 1.22B 1.2B 1.18B 1.16B 1.15B 1.14B 1.13B 1.12B 1.1B 1.09B 1.09B 1.1B 1.11B